DMAAR
Drugs Made In America Acquisition Corp. RightsNASDAQ
Updated 1 day ago
Coverage limited
$0.12+11.02%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- +6.3%
- 3 months
- +13.5%
- 1 year
- —
- 52-week range
- $0.04$0.22
- Dividend
- No dividends on record
- Short interest
- 0.3% of float61.1K shares · settled Sep 30, 2026 · -31.0% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if DMAAR is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
8 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
28 filers reported a long position in DMAAR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Polar Asset Management Partners Inc. | $209K | 1.9M | Unchanged |
| LINDEN ADVISORS LP | $97.8K | 850K | Unchanged |
| MANGROVE PARTNERS IM, LLC | $93.5K | 850K | Unchanged |
| TORONTO DOMINION BANK | $88K | 800K | +15.9% |
| Hudson Bay Capital Management LP | $83.5K | 758.7K | -55.4% |
| Clear Street Group Inc. | $78.2K | 711.1K | -0.1% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $77.3K | 857.5K | -17.9% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $62.7K | 418K | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC | $58.3K | 529.9K | -23.8% |
| Westchester Capital Management, LLC | $55K | 500K | Unchanged |
Get the Full Analysis for DMAAR
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.